Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twinrix Long-term Persistence (16-20 Years)
NCT01037114Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2010
- Primary completion
- Feb 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis A (HAV), hepatitis B (HBV), sponsored by GSK. Started Jan 2010; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01037114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037114.